RIMAN's Parent Company Announces Sponsored Research Agreement to Advance Araliadiol Using Organ-on-a-Chip Technology

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

RIMAN-Araliadiol

More Like This

PR Newswire associated0

RIMAN Connects APAC Markets in Macau Through Strategy, Innovation, and New Product Reveal

PR Newswire associated0

RIMAN Honored with iF DESIGN AWARD 2026, Strengthening Its Global Brand Leadership

PR Newswire associated0

RIMAN Ignites Momentum at 2026 North America Convention

PR Newswire associated0

RIMAN Officially Launches in London, Setting the Stage for European Market Growth

PR Newswire associated0

Amorepacific and Johns Hopkins School of Medicine's Joint Research Program 'NBRI' Participants Present Latest Findings

PR Newswire associated0

BioQ Debuts at in‑cosmetics Global, Showcasing China's Advancing Strength in Ingredient Innovation

PR Newswire associated0

Amorepacific Presents Latest Research at IFSCC

HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy, contains Angelica sinensis, Ligusticum chuanxiong, and Paeonia lactiflora. It was launched in Taiwan last month. (Photo: Kolmar BNH)

Kolmar BNH Sharpens Global Competitiveness with Dual Functionality of HemoHIM